Progressive Corp vs SELLAS Life Sciences Group Inc. Common Stock — how do they compare? Progressive Corp trades at $218.73 (market cap $124.28B), while SELLAS Life Sciences Group Inc. Common Stock trades at $11.34 (market cap $2.28B). The key difference: Progressive Corp is far larger — about 54.5× SELLAS Life Sciences Group Inc. Common Stock's market cap, and Progressive Corp pays a 0.19% dividend while SELLAS Life Sciences Group Inc. Common Stock pays none. Which is the better fit depends on your goals.
| PGR | SLS | |
|---|---|---|
Market Cap | $124.28B | $2.28B |
Volume | 2,551,191 | 3,128,960 |
Sector | Financials | Health |
52-Week High | $242.16 | $15.46 |
52-Week Low | $190.40 | $1.39 |
Typical Hold Time | 81 Days | — |
Enterprise Value | $132.48B | $2.15B |
Dividend Yield | 0.19% | — |
Signals from Pluang's Aura AI — not financial advice
PGR trades at $218.73, up 3.15% today, with a bullish technical signal from moving averages and strong fundamentals including a 12.85% net income margin and 34.94% ROE. Revenue grew from $49.6B in 2022 to $87.6B in 2025, with net income surging to $11.3B. The company recently announced a $0.10 dividend payable in October 2026, and Q2 2026 earnings beat expectations.
The outlook is positive given robust earnings growth and analyst consensus price target of $222.23, though risks include intensifying competition in personal auto insurance and potential market volatility. Institutional interest remains strong with recent position increases by funds like QRG Capital Management.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →